Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

TEX101 (testis expressed 101)

Identity

Alias_namestestis expressed sequence 101
Alias_symbol (synonym)MGC4766
SGRG
CT131
SPATA44
Other aliasGTPR867
NYD-SP8
PRO1884
TES101RP
HGNC (Hugo) TEX101
LocusID (NCBI) 83639
Atlas_Id 51745
Location 19q13.31  [Link to chromosome band 19q13]
Location_base_pair Starts at 43414883 and ends at 43418615 bp from pter ( according to hg38-Dec_2013)
Fusion genes
(updated 2016)
C4orf45 (4q32.1) / TEX101 (19q13.31)

Note

Non-annotated gene. Preliminary data : if you are an author
who wish to write a full paper/card on this gene, go to  How to contribute

DNA/RNA

 


External links

Nomenclature
HGNC (Hugo)TEX101   30722
Cards
Entrez_Gene (NCBI)TEX101  83639  testis expressed 101
AliasesCT131; GTPR867; NYD-SP8; PRO1884; 
SGRG; SPATA44; TES101RP
GeneCards (Weizmann)TEX101
Ensembl hg19 (Hinxton)ENSG00000131126 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000131126 [Gene_View]  chr19:43414883-43418615 [Contig_View]  TEX101 [Vega]
ICGC DataPortalENSG00000131126
TCGA cBioPortalTEX101
AceView (NCBI)TEX101
Genatlas (Paris)TEX101
WikiGenes83639
SOURCE (Princeton)TEX101
Genetics Home Reference (NIH)TEX101
Genomic and cartography
GoldenPath hg38 (UCSC)TEX101  -     chr19:43414883-43418615 +  19q13.31   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)TEX101  -     19q13.31   [Description]    (hg19-Feb_2009)
EnsemblTEX101 - 19q13.31 [CytoView hg19]  TEX101 - 19q13.31 [CytoView hg38]
Mapping of homologs : NCBITEX101 [Mapview hg19]  TEX101 [Mapview hg38]
OMIM612665   
Gene and transcription
Genbank (Entrez)AA417291 AF241268 AF353396 AY014285 AY359077
RefSeq transcript (Entrez)NM_001130011 NM_031451
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)TEX101
Cluster EST : UnigeneHs.97978 [ NCBI ]
CGAP (NCI)Hs.97978
Alternative Splicing GalleryENSG00000131126
Gene ExpressionTEX101 [ NCBI-GEO ]   TEX101 [ EBI - ARRAY_EXPRESS ]   TEX101 [ SEEK ]   TEX101 [ MEM ]
Gene Expression Viewer (FireBrowse)TEX101 [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
GenevisibleExpression in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)83639
GTEX Portal (Tissue expression)TEX101
Protein : pattern, domain, 3D structure
UniProt/SwissProtQ9BY14   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtQ9BY14  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProQ9BY14
Splice isoforms : SwissVarQ9BY14
PhosPhoSitePlusQ9BY14
Domains : Interpro (EBI)LY6_UPA_recep-like   
Domain families : Pfam (Sanger)UPAR_LY6 (PF00021)   
Domain families : Pfam (NCBI)pfam00021   
Conserved Domain (NCBI)TEX101
DMDM Disease mutations83639
Blocks (Seattle)TEX101
SuperfamilyQ9BY14
Human Protein AtlasENSG00000131126
Peptide AtlasQ9BY14
HPRD15490
IPIIPI00783012   IPI00020749   
Protein Interaction databases
DIP (DOE-UCLA)Q9BY14
IntAct (EBI)Q9BY14
FunCoupENSG00000131126
BioGRIDTEX101
STRING (EMBL)TEX101
ZODIACTEX101
Ontologies - Pathways
QuickGOQ9BY14
Ontology : AmiGOacrosomal membrane  extracellular region  plasma membrane  C-terminal protein lipidation  anchored component of membrane  
Ontology : EGO-EBIacrosomal membrane  extracellular region  plasma membrane  C-terminal protein lipidation  anchored component of membrane  
NDEx NetworkTEX101
Atlas of Cancer Signalling NetworkTEX101
Wikipedia pathwaysTEX101
Orthology - Evolution
OrthoDB83639
GeneTree (enSembl)ENSG00000131126
Phylogenetic Trees/Animal Genes : TreeFamTEX101
HOVERGENQ9BY14
HOGENOMQ9BY14
Homologs : HomoloGeneTEX101
Homology/Alignments : Family Browser (UCSC)TEX101
Gene fusions - Rearrangements
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerTEX101 [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)TEX101
dbVarTEX101
ClinVarTEX101
1000_GenomesTEX101 
Exome Variant ServerTEX101
ExAC (Exome Aggregation Consortium)TEX101 (select the gene name)
Genetic variants : HAPMAP83639
Genomic Variants (DGV)TEX101 [DGVbeta]
DECIPHERTEX101 [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisTEX101 
Mutations
ICGC Data PortalTEX101 
TCGA Data PortalTEX101 
Broad Tumor PortalTEX101
OASIS PortalTEX101 [ Somatic mutations - Copy number]
Somatic Mutations in Cancer : COSMICTEX101  [overview]  [genome browser]  [tissue]  [distribution]  
Mutations and Diseases : HGMDTEX101
LOVD (Leiden Open Variation Database)Whole genome datasets
LOVD (Leiden Open Variation Database)LOVD 3.0 shared installation
BioMutasearch TEX101
DgiDB (Drug Gene Interaction Database)TEX101
DoCM (Curated mutations)TEX101 (select the gene name)
CIViC (Clinical Interpretations of Variants in Cancer)TEX101 (select a term)
intoGenTEX101
Cancer3DTEX101(select the gene name)
Impact of mutations[PolyPhen2] [SIFT Human Coding SNP] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
Diseases
OMIM612665   
Orphanet
MedgenTEX101
Genetic Testing Registry TEX101
NextProtQ9BY14 [Medical]
TSGene83639
GENETestsTEX101
Target ValidationTEX101
Huge Navigator TEX101 [HugePedia]
snp3D : Map Gene to Disease83639
BioCentury BCIQTEX101
ClinGenTEX101
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD83639
Chemical/Pharm GKB GenePA134938764
Clinical trialTEX101
Miscellaneous
canSAR (ICR)TEX101 (select the gene name)
Probes
Litterature
PubMed16 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
CoreMineTEX101
EVEXTEX101
GoPubMedTEX101
iHOPTEX101
Genes in titleautomatic search in PubMed
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jun 7 12:59:06 CEST 2017

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.